Home › Bronchiolitis Obliterans Syndrome › Washington › Seattle
Bronchiolitis Obliterans Syndrome clinical trials in Seattle, WA
11 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
RecruitingPhase 2
- Fred Hutchinson Cancer Research Center- Site Number : 8400002, Seattle
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingPhase 2
- Fred Hutchinson Cancer Research Center, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RecruitingPhase 2
- Seattle Childrens Hospital, Seattle
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- Fred Hutchinson Cancer Research Center, Seattle
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Recruiting
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- Fred Hutchinson Cancer Research Center, Seattle
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Fred Hutchinson Cancer Research Center, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Los Angeles, CA7 studies
- Durham, NC6 studies
- Philadelphia, PA6 studies
- Columbus, OH6 studies
- Baldwin Park, CA6 studies
- Tampa, FL6 studies
- Washington, DC6 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.